83 results
S-1
EX-10.7
IVVD
Invivyd Inc
16 Jul 21
IPO registration
4:56pm
authorizations required for WuXi Biologics’ Manufacturing activities under this Agreement and Wuxi Biologics shall be solely responsible for acquiring … (a) shall manage the performance of the subcontractor at its sole cost and expense and (b) shall remain responsible to Client for all acts
DRS/A
EX-10.7
IVVD
Invivyd Inc
13 Jul 21
Draft registration statement (amended)
12:00am
authorizations required for WuXi Biologics’ Manufacturing activities under this Agreement and Wuxi Biologics shall be solely responsible for acquiring … (a) shall manage the performance of the subcontractor at its sole cost and expense and (b) shall remain responsible to Client for all acts
8-K
IVVD
Invivyd Inc
5 Sep 23
Invivyd Appoints William Duke As Chief Financial Officer
7:05am
Apexigen, Inc., where he served as Chief Financial Officer from June 2022 to August 2023 and was responsible for all areas of finance and accounting … Financial Officer of Kaleido Biosciences, Inc., where he was responsible for all areas of finance, accounting, and investor relations, implemented
8-K
EX-99.1
8v6 wl2cwdjft
6 Dec 22
Departure of Directors or Certain Officers
4:28pm
10-Q
EX-31.1
xayyt5w9zliub9h71
20 Sep 21
Quarterly report
4:17pm
DRS/A
EX-10.6
xb52j8xfk0 48
13 Jul 21
Draft registration statement (amended)
12:00am
UPLOAD
yrckew0kqkt 0q0wh2zr
30 Sep 22
Letter from SEC
12:00am
S-1
EX-10.6
b7valzyfl 72kt9csv
16 Jul 21
IPO registration
4:56pm
S-1
EX-10.5
upfl2p a5rid
16 Jul 21
IPO registration
4:56pm
DRS/A
EX-10.5
31vlsn8gphws8
13 Jul 21
Draft registration statement (amended)
12:00am
8-K
EX-10.2
msderi 1x
13 Oct 22
Invivyd Appoints Fred Driscoll as Interim Chief Financial Officer and Announces Resource Reallocation to Maximize Integrated Discovery
4:16pm
10-K
EX-31.2
4qa 46utkb2pgrsp4
31 Mar 22
Annual report
8:18am